BIOTECHNOLOGY
Next up for CRISPR: Gene editing for the masses?
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.
https://www.technologyreview.com/2023/01/19/1067074/next-for-crispr/
answer is built into the question, as usual.